A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects
Clinical trial NCT06090799 · COMPLETED
Trial details
- NCT number
- NCT06090799
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-29
- Primary completion
- 2024-03-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.